Johnson & Johnson Johnson & Johnson‚ one of the world’s leading healthcare products manufacturer‚ was founded in 1886 by three brothers‚ Robert Wood Johnson‚ James Wood Johnson and Edward Mead Johnson. In 1888‚ Johnson & Johnson pioneers the first commercial first aid kit and other key products such as‚ baby powder‚ baby oil‚ no tears shampoo and tylenol in the following years. With more than 275 companies located in more than 60 countries‚ Johnson & Johnson and it’s subsidiaries have approximately
Premium Johnson & Johnson Hip replacement
ESLG 0238 (T&F: 3:25-5:05) SITU SUIYAN (SUSAN) Diversity Plan of Johnson and Johnson I. Overview of company Johnson and Johnson company has a long history‚ which was founded in 1886 by Robert Wood Johnson‚ James Wood Johnson and Edward Mead Johnson in Brunsewick‚ New Jersey. Until now‚ Johnson and Johnson has 250 branches in over 57 countries‚ and it has nearly a hundred consumer brands with thousands of products sold in over 157 countries. The products are including medication‚ first aid
Premium Discrimination Johnson & Johnson
Subsidiaries analysis In modern time‚ Jansen‚ a subsidiary of the Pharmaceutical Company of Johnson & Johnson is tasked to recognize and solve the present incurable diseases. This few includes-- oncology‚ immunology‚ neuroscience‚ infectious diseases and vaccines‚ and cardiovascular and metabolic diseases. They are committed to bring innovative products‚ services and solutions to people around the globe as they realise the effect of the way diseases affect people on their daily routines thus the
Premium Medicine Health care Health
MG 496 Case #2 Johnson & Johnson (Case #21) External Factors Analysis • Economic I. Economic crisis directly affected R&D budget (2009) threat II. Currency rate fluctuations III. Change in consumer behaviors and spending patterns of health care products and services due to economic downfall. threat • Political/ Legal I. Government legislation relating to sales‚ promotions‚ and reimbursement II. Patent expirations (Patent Cliffs); could decrease demand for a
Premium Food and Drug Administration Pharmacology Advertising
I. Main Problem: J&J has observed that one of its baby products‚ Johnson’s Baby Powder‚ was being used by young female consumers in a different way from the product’s original usage purpose. Based on this observation‚ the company is considering launching a new product (“Johnson’s Face Powder”) targeting different segment (urban teen and young female adults between 16 and 25 years old‚ and from AB and C category economic households). The Face Powder is basically Johnson’s Baby Powder with several
Premium Cosmetics Marketing
Product Contamination of Johnson & Johnson MAN 3554-1 Workplace Continuity & Contingency Planning – 1 Michelle Alderman Everest College June 8‚ 2014 The company I chose to write about is Johnson & Johnson and its crisis with Tylenol. Back in 1982 for reasons they did not know due to the “acts of a malevolent person or persons‚ presumably unknown‚ replaced Tylenol Extra-Strength capsules with cyanide-laced capsules‚ resealed the packages‚ and deposited them on the shelves of at least a half-dozen
Premium Consumer Consumer protection Johnson & Johnson
I. Main Problem: J&J has observed that one of its baby products‚ Johnson’s Baby Powder‚ was being used by young female consumers in a different way from the product’s original usage purpose. Based on this observation‚ the company is considering launching a new product (“Johnson’s Face Powder”) targeting different segment (urban teen and young female adults between 16 and 25 years old‚ and from AB and C category economic households). The Face Powder is basically Johnson’s Baby Powder with several
Premium Cosmetics Marketing
The $10‚000 investment made into Johnson and Johnson is a good investment to have in your portfolio. This is because of the stable nature of Johnson and Johnson and the growth trend of the company. Based on the JNJ 10-Ks for the last 5 years ended Jan. 1‚ 2012‚ the revenue trend is growing. Revenues have trended favorably from $61‚095 in the year ended Jan. 2007 to $65‚030 in the year ended Jan. 1‚ 2012. The company is also operating efficiently showing the more stable aspect of this investment
Premium Investment Asset Financial ratios
Johnson & Johnson: Successfully Strategizing for the Changing Global Business Environment I. Introduction Johnson & Johnson is the world’s largest healthcare company. Founded in the United States in 1886‚ the company has been profitable for 75 straight years and currently operates 250 subsidiary companies in 57 countries. Its products fall into three segments: pharmaceuticals‚ with 39% of total sales; medical devices and diagnostics‚ with 36%;
Premium Generic drug Pharmaceutical industry Medicine
Johnson & Johnson (A) Philosophy & Culture Case Analysis Introduction: Johnson & Johnson (J&J) was founded 121 years ago based on the need for sterile medical supplies to treat patient’s wounds. Post-operative mortality rates were a grim 90% and after attending a seminar on “antisepsis” Robert Wood Johnson‚ an apothecary‚ saw this as an opportunity to start a much needed company. With $100‚000 in capital and the help of his brothers‚ James and Edward‚ they established Johnson & Johnson
Premium Health care Johnson & Johnson Medicine